Joseph Gera

University of California, Los Angeles — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

32h-index4.3kcitations155works9.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PI3K/AKT/mTOR signaling in cancer(73), Multiple Myeloma Research and Treatments(51), Protein Degradation and Inhibitors(13), RNA Research and Splicing(11), Hippo pathway signaling and YAP/TAZ(10)

Publications155 total

A lupus-derived autoantibody that binds to intracellular RNA activates cGAS-mediated tumor immunity and can deliver RNA into cells
Science Signaling·2025· 9 cited
Retraction Note: Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress
Oncogene·2023Open Access
Editorial Expression of Concern: MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells
Oncogene·2023Open Access
Cellular protection from H2O2 toxicity by Fv-Hsp70: protection via catalase and gamma-glutamyl-cysteine synthase
Cell Stress and Chaperones·2023· 2 citedOpen Access
Translation of circHGF RNA encodes an HGF protein variant promoting glioblastoma growth through stimulation of c-MET
Journal of Neuro-Oncology·2023· 15 citedOpen Access
m6A-modification of cyclin D1 and c-myc IRESs in glioblastoma controls ITAF activity and resistance to mTOR inhibition
Cancer Letters·2023· 18 citedOpen Access
Data from Inhibition of SAPK2/p38 Enhances Sensitivity to mTORC1 Inhibition by Blocking IRES-Mediated Translation Initiation in Glioblastoma
2023Open Access
Supplementary Figure 2 from Inhibition of SAPK2/p38 Enhances Sensitivity to mTORC1 Inhibition by Blocking IRES-Mediated Translation Initiation in Glioblastoma
2023Open Access
Supplementary Figure Legends 1-3 from Inhibition of SAPK2/p38 Enhances Sensitivity to mTORC1 Inhibition by Blocking IRES-Mediated Translation Initiation in Glioblastoma
2023Open Access
Supplementary Figure 2 from Inhibition of SAPK2/p38 Enhances Sensitivity to mTORC1 Inhibition by Blocking IRES-Mediated Translation Initiation in Glioblastoma
2023Open Access
Data from Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma
2023Open Access
Figure S1 from A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity
2023Open Access
figure S8 from A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity
2023Open Access
figure S7 from A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity
2023Open Access
figure S5 from A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity
2023Open Access
Interview with Dr. Mischel from Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance
2023Open Access
Interview with Dr. Mischel from Oncogenic EGFR Signaling Activates an mTORC2–NF-κB Pathway That Promotes Chemotherapy Resistance
2023Open Access
Figure S2 from A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity
2023Open Access
figure S6 from A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity
2023Open Access
Supplementary Figure 3 from Inhibition of SAPK2/p38 Enhances Sensitivity to mTORC1 Inhibition by Blocking IRES-Mediated Translation Initiation in Glioblastoma
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Alan Lichtenstein(31), Yijiang Shi(19), Brent Holmes(17), Patrick Frost(13), Bao Hoang(12), Angelica Benavides-Serrato(12), Robert N. Nishimura(9), Janine Masri(8), Andrew Bernath(8), Cheri Cloninger(8), Tariq Bashir(8), Jheralyn Martin(7), Nicholas Artinian(7), Jacquelyn T. Saunders(5), Lauren Anderson(5), Huajun Yan(4), Jung-Hsin Hsu(4), Alexander Funk(4), Angelica Benavides(4), Kenna A. Landon(4)